1. Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis 
Gian Luca Di Tanna, PhD, Ali Raza Khaki, MD, Grant Theron, PhD, Kerrigan McCarthy, MBBCh, Helen Cox, PhD, Lucy Mupfumi, MPH, Anete Trajman, MD, Lynn Sodai Zijenah, PhD, Peter Mason, PhD, Tsitsi Bandason, PhD, Betina Durovni, MD, Wilbert Bara, MD, Michael Hoelscher, MD, Petra Clowes, MD, Chacha Mangu, MD, Duncan Chanda, MD, Prof Alexander Pym, MD, Peter Mwaba, MD, Prof Frank Cobelens, MD, Mark P Nicol, PhD, Prof Keertan Dheda, PhD, Prof Gavin Churchyard, PhD, Katherine Fielding, PhD, John Z Metcalfe, MD 
The Lancet Global Health 
Volume 7, Issue 2, Pages e191-e199 (February 2019)
DOI: /S X(18)
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

2. Figure 1 Study selection
RCT=randomised controlled trial. *The primary outcome was limited to three studies15,17,18 (n=8142), as Mupfumi and colleagues16 limited follow-up to 3 months.
The Lancet Global Health 2019 7, e191-e199DOI: ( /S X(18) )
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

3. Figure 2 Kaplan-Meier pooled survival estimates
Shaded areas represent 95% CIs.
The Lancet Global Health 2019 7, e191-e199DOI: ( /S X(18) )
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions